Association between Low-Activity Allele of Cathecolamine-O-Methyl-Transferase (COMT) and Borderline Personality Disorder in an Italian Population
- 1 April 2013
- journal article
- research article
- Published by Taylor & Francis in Behavioral Medicine
- Vol. 39 (2) , 25-28
Abstract
The objective of the present study was to test the association between Borderline Personality Disorder (BPD) and the cathecolamine-O-methyl-transferase (COMT) low-activity (Met158) single nucleotide polymorphism (SNP). In this case-control study, DNA was obtained from venous blood of 19 BPD patients and 36 healthy subjects. COMT-Val158Met single-nucleotide polymorphism was genotyped by predesigned SNP assay. The COMT Met158 allele was over-represented in patients with BPD in comparison to normal subjects (68.4% vs 44.4%, respectively; Fisher exact test, p = .02). In terms of genotype, the Met158Met subjects were more frequent in patients versus controls (47.4% vs 22.2%, respectively), whereas the high-activity genotype Val158Val was under-represented (10.5% vs 33.3%, respectively). The allele encoding for the COMT with low enzymatic efficiency was found to be over-represented in BPD, possibly resulting in excessive synaptic dopaminergic activity and ultimately affecting externalizing behaviours, such as impulsivity and aggressiveness.Keywords
This publication has 14 references indexed in Scilit:
- Multifinality in the development of personality disorders: A Biology × Sex × Environment interaction model of antisocial and borderline traitsDevelopment and Psychopathology, 2009
- Neural correlates of episodic and semantic memory retrieval in borderline personality disorder: An fMRI studyPsychiatry Research: Neuroimaging, 2009
- Interaction between gene variants of the serotonin transporter promoter region (5‐HTTLPR) and catechol O‐methyltransferase (COMT) in borderline personality disorderAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008
- Neurobiology of Aggression and ViolenceAmerican Journal of Psychiatry, 2008
- Catechol-O-Methyltransferaseval158metGenotype Affects Processing of Emotional Stimuli in the Amygdala and Prefrontal CortexJournal of Neuroscience, 2005
- Stress and hippocampal abnormalities in psychiatric disordersEuropean Neuropsychopharmacology, 2004
- Empirical Evidence and Psychotherapy: A Growing Scientific BaseAmerican Journal of Psychiatry, 2001
- Dialectical Behavior Therapy for Patients with Borderline Personality Disorder and Drug‐DependenceThe American Journal on Addictions, 1999
- METHYLATION PHARMACOGENETICS: Catechol O-Methyltransferase, Thiopurine Methyltransferase, and Histamine N-MethyltransferaseAnnual Review of Pharmacology and Toxicology, 1999
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996